Prognostic utility of albumin‐bilirubin grade for short‐ and long‐term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi‐institutional analysis of 706 patients. Issue 2 (25th April 2019)
- Record Type:
- Journal Article
- Title:
- Prognostic utility of albumin‐bilirubin grade for short‐ and long‐term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi‐institutional analysis of 706 patients. Issue 2 (25th April 2019)
- Main Title:
- Prognostic utility of albumin‐bilirubin grade for short‐ and long‐term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi‐institutional analysis of 706 patients
- Authors:
- Tsilimigras, Diamantis I.
Hyer, J. Madison
Moris, Dimitrios
Sahara, Kota
Bagante, Fabio
Guglielmi, Alfredo
Aldrighetti, Luca
Alexandrescu, Sorin
Marques, Hugo P.
Shen, Feng
Koerkamp, B. Groot
Endo, Itaru
Pawlik, Timothy M. - Abstract:
- Abstract: Background: The objective of the current study was to define the impact of albumin‐bilirubin (ALBI) grade on short‐ as well as long‐term outcomes among patients with intrahepatic cholangiocarcinoma (ICC). Methods: Patients who underwent hepatectomy for ICC between 1990 and 2016 were identified using an international multi‐institutional database. Clinicopathologic factors including ALBI score were assessed using bivariate and multivariable analyses, as well as standard survival analyses. Results: Among 706 patients, 453 (64.2%) patients had ALBI grade 1, 231 (32.7%) ALBI grade 2, and 22 (3.1%) had ALBI grade 3. After adjusting for all competing factors, patients with ALBI grade 2/3 had higher odds of a prolonged length‐ of‐ stay (>10 days, odds ratio [OR] = 2.37, 95% confidence interval [CI]:1.47‐3.80), perioperative transfusion (OR = 2.15, 95% CI:1.45‐3.18) and 90‐day mortality (OR = 2.50, 95% CI:1.16‐5.38). Median and 5‐year overall survival (OS) for the entire cohort was 41.5 months (IQR:15.7‐107.8) and 39.8%, respectively. Of note, median OS incrementally worsened with increased ALBI grade: grade 1, 49.6 months (IQR:18.3‐NR) vs grade 2, 29.6 months (IQR:12.6‐98.4) vs grade 3, 16.9 months (IQR:6.5‐32.4; P < 0.001). On multivariable analysis, higher ALBI grade remained associated with higher hazards of death (grade 2/3: hazard ratio = 1.36, 95% CI:1.04‐1.78). Conclusion: The ALBI score was associated with both short‐ and long‐term outcomes following resection forAbstract: Background: The objective of the current study was to define the impact of albumin‐bilirubin (ALBI) grade on short‐ as well as long‐term outcomes among patients with intrahepatic cholangiocarcinoma (ICC). Methods: Patients who underwent hepatectomy for ICC between 1990 and 2016 were identified using an international multi‐institutional database. Clinicopathologic factors including ALBI score were assessed using bivariate and multivariable analyses, as well as standard survival analyses. Results: Among 706 patients, 453 (64.2%) patients had ALBI grade 1, 231 (32.7%) ALBI grade 2, and 22 (3.1%) had ALBI grade 3. After adjusting for all competing factors, patients with ALBI grade 2/3 had higher odds of a prolonged length‐ of‐ stay (>10 days, odds ratio [OR] = 2.37, 95% confidence interval [CI]:1.47‐3.80), perioperative transfusion (OR = 2.15, 95% CI:1.45‐3.18) and 90‐day mortality (OR = 2.50, 95% CI:1.16‐5.38). Median and 5‐year overall survival (OS) for the entire cohort was 41.5 months (IQR:15.7‐107.8) and 39.8%, respectively. Of note, median OS incrementally worsened with increased ALBI grade: grade 1, 49.6 months (IQR:18.3‐NR) vs grade 2, 29.6 months (IQR:12.6‐98.4) vs grade 3, 16.9 months (IQR:6.5‐32.4; P < 0.001). On multivariable analysis, higher ALBI grade remained associated with higher hazards of death (grade 2/3: hazard ratio = 1.36, 95% CI:1.04‐1.78). Conclusion: The ALBI score was associated with both short‐ and long‐term outcomes following resection for ICC and could prove a useful surrogate marker to identify patients at risk for adverse outcomes. … (more)
- Is Part Of:
- Journal of surgical oncology. Volume 120:Issue 2(2019)
- Journal:
- Journal of surgical oncology
- Issue:
- Volume 120:Issue 2(2019)
- Issue Display:
- Volume 120, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 120
- Issue:
- 2
- Issue Sort Value:
- 2019-0120-0002-0000
- Page Start:
- 206
- Page End:
- 213
- Publication Date:
- 2019-04-25
- Subjects:
- albumin -- bilirubin -- complications -- ICC -- overall survival
Cancer -- Surgery -- Periodicals
Neoplasms -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9098 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jso.25486 ↗
- Languages:
- English
- ISSNs:
- 0022-4790
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5067.380000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11045.xml